Menu

Thinking Digital: When qPCR Doesn’t Make the Cut

Bio-Rad experts Eddy van Collenburg and Jörg Bantin will discuss where your research can greatly benefit from using ddPCR rather than qPCR, as well as how to ensure a seamless transition to ddPCR.

The Creative Services Team in collaboration with Bio-Rad Laboratories
Oct 20, 2021

Expert Discussion

Thursday, November 4, 2021
4:00 PM Central European Time (11:00 AM ET)

Register Now

Quantitative PCR (qPCR) is one of the most widely used tools in genomics. It is so powerful and user-friendly that researchers tend to over rely on it. Every technique has its limitations, and qPCR is no exception. There are situations where a more refined PCR technique such as Droplet Digital PCR (ddPCR) could yield superior results. In this webinar brought to you by Bio-Rad, Jörg Bantin and Eddy van Collenburg will discuss when ddPCR should be used instead of qPCR and how to ease the transition.

Topics to be covered

  • The seamless shift from qPCR to ddPCR
  • Applications where qPCR is not good enough
  • The brave new world of ddPCR applications 

Register Now

Meet the Speaker:

Jörg Bantin, PhD
Regional Specialist, ddPCR
Bio-Rad, Germany


Eddy van Collenburg
Market Development Specialist, ddPCR
Bio-Rad, Netherlands


December 2021

Return of the worms

Researchers are carefully considering the therapeutic potential of helminths

Marketplace

Sponsored Product Updates

Using 3-D Cell Culture Systems for Extracellular Vesicle Research
3-D cell culture recapitulates in vivo environments for generating physiologically relevant extracellular vesicles.
On the Path to Personalized Medicine
Scientists combine medical care with biobanking and research to develop personalized treatments for cancer patients.
An Early Start: The Impact of the Microbiome on Pediatric Development in the First Year of Life
A better understanding of early childhood microbiome shifts offers a unique window for detecting disease risk and intervening appropriately.
Dr. Aletta Schnitzler Joins TurtleTree as Chief Scientific Officer
Cell-based nutrition company TurtleTree welcomes Dr. Aletta Schnitzler as its new Chief Scientific Officer (CSO). With her world-class expertise in cellular bioprocessing, Dr. Schnitzler’s appointment marks a significant stride in TurtleTree’s journey towards sustainable and efficient cellular food production.